Anti-Obesity Drug Discovery and Development Impact factor 2025

---

The latest impact factor of Anti-Obesity Drug Discovery and Development and all the other Web of Science journals was released on 20th June 2025 by Clarivate. Through this web page, researchers can check the impact factor, total citation, journal quartile, and journal aim & scope.

Anti-Obesity Drug Discovery and Development: Aim & Scope

Anti-Obesity Drug Discovery and Development is a Web of Science indexed journal tha publishes research in the area: Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4).
The ISSN of this journal is 22102698, 24679615.

Impact factor of Anti-Obesity Drug Discovery and Development

Journal Title	Anti-Obesity Drug Discovery and Development
Impact Factor
SJR	0.131
ISSN	22102698, 24679615
Quartile	Q4

The Journal Impact Factor is defined as citations to the journal in the JCR year to items published in the previous two years, divided by the total number of scholarly items, also known as citable items, (these comprise articles and reviews) published in the journal in the previous two years.

Impact factor data has a strong influence on the scientific community, affecting decisions on where to publish, whom to promote or hire, the success of grant applications, and even salary bonuses.

Only journals listed in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI) receive an Impact Factor.

Similiar journals to publish

---

Anti-Obesity Drug Discovery and Development

ISSN: 22102698, 24679615
Journal Impact:
Journal Scope: Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)

Recent Patents on Anti-Cancer Drug Discovery

ISSN: 22123970
Journal Impact: 2.5
Journal Scope: Oncology | Pharmacology & Pharmacy

Recent Advances in Anti-Infective Drug Discovery

ISSN: 27724352
Journal Impact:
Journal Scope: Drug Discovery (Q3); Infectious Diseases (Q3); Pharmacology (medical) (Q3)

Frontiers in Anti-infective Drug Discovery

ISSN: 1879663X, 24519162
Journal Impact:
Journal Scope: Drug Discovery (Q4); Infectious Diseases (Q4); Molecular Medicine (Q4)

Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry

ISSN: 1875614X
Journal Impact:
Journal Scope: Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4); Immunology and Allergy (Q4)

Frontiers in Clinical Drug Research - Anti Infectives

ISSN: 24523208, 23523212
Journal Impact:
Journal Scope: Drug Discovery (Q4); Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)

Frontiers in Clinical Drug Research - Anti Allergy Agents

ISSN: 22146938, 24523194
Journal Impact:
Journal Scope: Drug Discovery (Q4); Immunology and Allergy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)

Current Research in Pharmacology and Drug Discovery

ISSN: 25902571
Journal Impact:
Journal Scope: Animal Science and Zoology (Q1); Ecology, Evolution, Behavior and Systematics (Q1)

Letters in Drug Design and Discovery

ISSN: 15701808
Journal Impact:
Journal Scope: Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)

Recent Advances in Inflammation and Allergy Drug Discovery

ISSN: 27722716
Journal Impact:
Journal Scope:

About SCI

SCI is a multidisciplinary citation index. Science Citation Index covers 9,000+ journals across 177 scientific disciplines. SCI was established in 1900 to the current. SCI-indexed journals are indexed by SCI and SSCI. SCI is described as the world's leading journal.

All journals covered in this database are reviewed for sufficiently high quality each year.

How to publish in SCI journals?